About Marine Pharmaceuticals
Marine pharmaceuticals include all the drugs that are obtained from the marine source. These drugs are used for the treatment of various diseases such as cancer, heart diseases, and infections.

Our analysts forecast the Global Marine Pharmaceuticals Market to grow at a CAGR of 7.28% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global marine pharmaceuticals market. To calculate the market size, the report considers the revenue generated from the sales of oncology drugs primarily along with cardiovascular, anti-infectives, and others.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Our report, global marine pharmaceuticals market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• GlaxoSmithKline
• Jazz Pharmaceuticals
• PharmaMar
• Seattle Genetics.

Market driver
• Special drug designations
• For a full, detailed list, view our report

Market challenge
• Regular supply of marine organisms and compounds
• For a full, detailed list, view our report

Market trend
• Marine peptides as anti-infectives
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.